2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow CCV-AV protocol: new trials by email Literature Review of CCV-AV protocol trials Research Report on CCV-AV protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment Cvac, Placebo - Epithelial Ovarian Cancer | Phase 2 | Terminated | Prima BioMed Ltd | 91 | 2012-01-01 | 2016-12-14 |
| Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study MUC1 Dendritic Cell Vaccine (Cvac) - Epithelial Ovarian Cancer | Phase 2 | Completed | Prima BioMed Ltd | 9 | 2011-12-01 | 2017-12-08 |
| Ovarian Cancer Vaccine for Patients in Remission Cvac - Epithelial Ovarian Cancer | Phase 2 | Completed | Prima BioMed Ltd | 63 | 2010-07-01 | 2017-05-11 |
Carcinoma, Ovarian Epithelial (3)
Prima BioMed Ltd (3)
Australia (3) · United States (3)
Fernando Recio, MD (2) · Giuseppe Del Priore, MD (2) · James Mason, MD (2) · Peter Eisenberg, MD (2) · Angeles Secord, MD (1) · Benedict Benigno, MD (1) · Heidi Gray, MD (1) · Heidy Gray, MD (1) · Jeffery Goh, MBBS, FRACP (1) · Jeffrey Goh, MBBS, FRACP (1) · Jennifer Young, MD (1) · John Chan, MD (1) · Jonathan Berek, MD, MMS (1) · Linda Mileshkin, MBBS (1) · Marco Matos, FRACP (1)